• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Tuesday, August 9, 2022
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Treatment advances have not improved long-term health status of childhood cancer survivors

Bioengineer by Bioengineer
November 7, 2016
in Science News
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

1. Decades of treatment advances have not improved long-term health outcomes for childhood cancer survivors
Abstract: http://annals.org/aim/article/doi/10.7326/M16-0742
URLs go live when the embargo lifts

Despite therapeutic advances over the past 30 years, adult survivors of childhood cancer continue to report poor physical and mental health status. The findings are published in Annals of Internal Medicine.

Advances in treatment and supportive care have led to improved survival for patients with childhood cancer. As adults, survivors may suffer from chronic medical conditions resulting from specific therapies and up to 25 percent report adverse health status in their 20s and 30s. Whether or not survivors treated with less toxic contemporary therapies have better health outcomes has not been evaluated.

Researchers compared the self-reported health status by treatment decade (70s, 80s, or 90s) of 14,566 adult cancer survivors who participated in the Childhood Cancer Survivor Study (CCSS) to that of their siblings to determine associations between treatment decade and adverse health status. Patient diagnosis, cancer treatment exposure, chronic health conditions, demographic characteristics, and health habits were considered in the evaluation. The researchers hypothesized that patients treated in the 90s with contemporary therapy would report better health status than those treated in the 70s.

Despite an overall decline in radiation exposure, reduced mean chemotherapy doses, and decreased proportions of survivors with more severe chronic health conditions, patient-reported health status generally did not improve across treatment decade. Contrary to the researchers' assumption, the percentage of survivors reporting poor general health and cancer-related anxiety was highest among those treated in the 90s and lowest among those treated in the 70s. The authors suggest that survivors treated in a more recent era may have access to more organized follow-up care and educational materials about late effects of treatment and, therefore, may be more likely to anticipate or report adverse outcomes. As with the general population, demographic characteristics and high-risk health behaviors, such as smoking, were associated with an increased risk for adverse health status.

Note: For an embargoed PDF, please contact Cara Graeff. To reach the lead author, Kirsten K. Ness, PT, PhD, please contact the St. Jude's media department at [email protected]

Also new in this issue:

America, We Are Confused: The Updated U.S. Preventive Services Task Force Recommendation on Colorectal Cancer Screening
Michael Bretthauer, MD, PhD; Michal F. Kaminski, MD, PhD; Cesare Hassan, MD; Mette Kalager, MD, PhD; Øyvind Holme, MD, PhD; Geir Hoff, MD, PhD; Magnus Løberg, MD, PhD; Jaroslaw Regula, MD, PhD; Antoni Castells, MD, PhD; and Hans-Olov Adami, MD, PhD
Ideas and Opinions
Abstract: http://annals.org/aim/article/doi/10.7326/M16-1805

Can Knowledge About Heterogeneity in Treatment Effects Help Us Choose Wisely?
Frank Davidoff, MD
Ideas and Opinions
Abstract: http://annals.org/aim/article/doi/10.7326/M16-1721

###

Media Contact

Cara Graeff
[email protected]
215-351-2513
@ACPinternists

http://www.acponline.org

Share12Tweet8Share2ShareShareShare2

Related Posts

Genetic scissors

Gene editing via CRISPR/Cas9 can lead to cell toxicity and genome instability

August 9, 2022
Bumblebee on wild clary

New online resource can help users ‘bee’ friendly when it comes to planting for pollinators

August 9, 2022

Leadership online: Charisma matters most in video communication

August 9, 2022

Gwangju Institute of Science and Technology scientists improve the power output of triboelectric nanogenerators with carbon particles

August 9, 2022
Please login to join discussion

POPULAR NEWS

  • Picture of the horse specimen.

    Ancient DNA clarifies the early history of American colonial horses

    56 shares
    Share 22 Tweet 14
  • The pair of Orcas deterring Great White Sharks – by ripping open their torsos for livers

    66 shares
    Share 26 Tweet 17
  • Ill-fated ‘Into the Wild’ adventurer was victim of unfortunate timing, Oregon State study suggests

    39 shares
    Share 16 Tweet 10
  • Skin: An additional tool for the versatile elephant trunk

    38 shares
    Share 15 Tweet 10

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

Urogenital SystemVaccinesViolence/CriminalsVirologyZoology/Veterinary ScienceUniversity of WashingtonVirusUrbanizationVehiclesWeaponryWeather/StormsVaccine

Recent Posts

  • Gene editing via CRISPR/Cas9 can lead to cell toxicity and genome instability
  • New online resource can help users ‘bee’ friendly when it comes to planting for pollinators
  • Leadership online: Charisma matters most in video communication
  • Gwangju Institute of Science and Technology scientists improve the power output of triboelectric nanogenerators with carbon particles
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In